Molecular Diagnostic Laboratories who are performing comprehensive NGS testing may request to become a participant in the CureOne N1 Registry. A lab can utilize the N1 Registry as an independent and honest broker for clinical data collection to satisfy payer requirements, demonstrate clinical evidence, or to improve quality of testing.
Oncologists can provide sequencing for patients covered by insurers, learn more about molecular medicine through a shared database of genomics and outcomes, obtain access to rich data sources for research, access clinical trials and greatly advance research in precision medicine.
Patients can receive advanced testing that is paid for by insurers, and can help advance personalized medicine in a very important and powerful manner. Ask your Oncologist how you might qualify for participation.